Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-116334
Filing Date
2024-10-22
Accepted
2024-10-22 17:07:15
Documents
2
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2197
2 EX-24 evok-ex24.htm EX-24 12333
  Complete submission text file 0000950170-24-116334.txt   15952
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2221 OLYMPIC BLVD. WALNUT CREEK CA 94561
Business Address
Smeal Benjamin C. (Reporting) CIK: 0001748561 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 241386986